Technical Analysis for APLI - Appili Therapeutics Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Narrow Range Bar | Range Contraction | 14.29% | |
| Wide Bands | Range Expansion | 14.29% | |
| Fell Below 20 DMA | Bearish | 14.29% | |
| Fell Below 200 DMA | Bearish | 14.29% | |
| NR7 | Range Contraction | 14.29% | |
| Narrow Range Bar | Range Contraction | 14.29% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 11 hours ago |
| Rose Above 200 DMA | about 11 hours ago |
| Fell Below 200 DMA | about 11 hours ago |
| Rose Above Previous Day's High | 4 days ago |
| Rose Above 20 DMA | 4 days ago |
Free Daily (Stock) Chart Reading
- Earnings date: 2024-02-12
Appili Therapeutics Inc Description
Appili Therapeutics Inc is a Canada-based anti-infective pharmaceutical development company. The Company focuses on identifying, acquiring and advancing therapeutics for infectious disease. The Company is engaged in developing strategies to develop new classes of antibiotics and anti-infectives to the clinic to improve treatment and health of patients suffering from infection. The Company has over two anti-infective programs, which include ATI-1501 and ATI-1503. The Company's ATI-1501 is a taste-masked treatment for clostridium difficile infection. The Company's ATI-1503 is an antibiotic with a potential to treat Gram-negative infections, such as Klebsiella pneumoniae. The Company’s agents focus on the therapeutics, including antivirals, antifungals, antiparasitics and antimicrobials, which can treat the hospital and community acquired infections caused by multi-drug resistant pathogens.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Disease Bacteria Infection Antibiotic Antimicrobial Anti Infectives Antibiotics Organisms Antivirals Biocides Infections Infectious Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.08 |
| 52 Week Low | 0.025 |
| Average Volume | 240,477 |
| 200-Day Moving Average | 0.040 |
| 50-Day Moving Average | 0.034 |
| 20-Day Moving Average | 0.039 |
| 10-Day Moving Average | 0.040 |
| Average True Range | 0.004 |
| RSI (14) | 53.05 |
| ADX | 12.05 |
| +DI | 32.154 |
| -DI | 28.778 |
| Chandelier Exit (Long, 3 ATRs) | 0.047 |
| Chandelier Exit (Short, 3 ATRs) | 0.038 |
| Upper Bollinger Bands | 0.052 |
| Lower Bollinger Band | 0.026 |
| Percent B (%b) | 0.53 |
| BandWidth | 67.519 |
| MACD Line | 0.001 |
| MACD Signal Line | 0.002 |
| MACD Histogram | -0.0008 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.040 | ||||
| Resistance 3 (R3) | 0.040 | 0.040 | 0.040 | ||
| Resistance 2 (R2) | 0.040 | 0.040 | 0.040 | 0.040 | |
| Resistance 1 (R1) | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
| Pivot Point | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
| Support 1 (S1) | 0.040 | 0.040 | 0.040 | 0.040 | 0.040 |
| Support 2 (S2) | 0.040 | 0.040 | 0.040 | 0.040 | |
| Support 3 (S3) | 0.040 | 0.040 | 0.040 | ||
| Support 4 (S4) | 0.040 |
